Breaking News - The Fly

Open Search

RIGL

Rigel Pharmaceuticals

$

()

Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial

RIGL

9/5/2024 - 07:32am

Rigel Pharmaceuticals enters license and supply agreement with Kissei Pharma

RIGL

9/3/2024 - 08:08am

Rigel Pharmaceuticals price target raised by $15.25 at B. Riley, here's why

RIGL

8/7/2024 - 08:40am

Rigel Pharmaceuticals target adjusted to $57 from $15 at H.C. Wainwright

RIGL

8/7/2024 - 06:12am

Rigel Pharmaceuticals reports Q2 EPS (6c), consensus (29c)

RIGL

8/6/2024 - 16:08pm

Rigel Pharmaceuticals files $250M mixed securities shelf

RIGL

8/2/2024 - 16:54pm

Biotech Alert: Searches spiking for these stocks today

DMAC , WVE , ORMP

…

6/28/2024 - 10:06am

Rigel Pharmaceuticals trading halted, news pending

RIGL

6/26/2024 - 19:50pm

Rigel Pharmaceuticals announces 1-for-10 reverse stock split

RIGL

6/25/2024 - 08:06am

Rigel Pharmaceuticals completes transfer of GAVRETO NDA

RIGL

6/24/2024 - 16:06pm

Rigel Pharmaceuticals highlights new data in three poster presentations at ASCO

RIGL

6/3/2024 - 08:16am

Rigel Pharmaceuticals announces presentations at upcoming ASCO

RIGL

5/23/2024 - 17:32pm

Rigel Pharmaceuticals reports Q1 EPS (5c), consensus (3c)

RIGL

5/7/2024 - 16:02pm

Rigel Pharmaceuticals' olutasidenib shows efficacy in published AML study

RIGL

4/4/2024 - 08:11am

Rigel Pharmaceuticals names Lisa Rojkjaer, M.D. as Chief Medical Officer

RIGL , SGMO

3/12/2024 - 08:08am